Company News in the Life Science Industry

»

Reset 

Innovation Pharmaceuticals – Clinical Trial Testing of Brilacidin Against SARS-CoV-2 (COVID-19) Targeted to Commence Q4 2020

Read more ››
By: GlobenewsWire - 13 Jul 2020
Related companies:  Innovation Pharmaceuticals Inc.

SimonMed Imaging Accelerates Nationwide Deployment of iCAD’s ProFound AI™

Read more ››
By: GlobenewsWire - 13 Jul 2020

PetMed Express d/b/a 1-800-PetMeds to Announce Its First Quarter Financial Results on July 20, 2020

Read more ››
By: GlobenewsWire - 13 Jul 2020

Avadel Pharmaceuticals Announces First Patient Dosed in Open-Label Extension/Switch Study of Investigational Once-Nightly FT218 as a Potential Treatment for Excessive Daytime Sleepiness and Cataplexy in Patients with Narcolepsy

Read more ››
By: GlobenewsWire - 13 Jul 2020
Related companies:  Avadel Pharmaceuticals plc

Protech Home Medical to Virtually Attend the Canaccord Genuity 40th Annual Growth Conference on August 11th – 13th

Read more ››
By: GlobenewsWire - 13 Jul 2020

Catalyst Biosciences Presents Data at the International Society for Thrombosis and Haemostasis (ISTH) Virtual Congress

Read more ››
By: GlobenewsWire - 13 Jul 2020
Related companies:  Catalyst Biosciences, Inc.

Orchestra BioMed™ Appoints Drug-Device Combination Expert Jagdish Parasrampuria as Vice President of Pharmaceutical Development

Read more ››
By: GlobenewsWire - 13 Jul 2020
Related companies:  Orchestra BioMed, Inc.

ASLAN Pharmaceuticals Reports Second Quarter 2020 Financial Results and Provides Corporate Update

Read more ››
By: GlobenewsWire - 13 Jul 2020

TRACON Pharmaceuticals to Host Key Opinion Leader Webinar on Envafolimab for the Treatment of Sarcoma

Read more ››
By: GlobenewsWire - 13 Jul 2020
Related companies:  TRACON Pharmaceuticals, Inc.

Press release Oncology Venture acquires full ownership of its PARP inhibitor (2X-121) program

Read more ››
By: GlobenewsWire - 13 Jul 2020

Enzo Biochem Receives Emergency Use Authorization for Proprietary Test System for Detection of Coronavirus SARS-CoV-2

Read more ››
By: GlobenewsWire - 13 Jul 2020

Bellerophon Therapeutics Announces First Patient Treated in Phase 3 Clinical Study of INOpulse® Inhaled Nitric Oxide Therapy for COVID-19

Read more ››
By: GlobenewsWire - 13 Jul 2020
Related companies:  Bellerophon Therapeutics, Inc.

Syneos Health Signs New Service Agreement With Pfizer

Read more ››
By: GlobenewsWire - 13 Jul 2020
Related companies:  Syneos Health, Inc

Adverum Biotechnologies Announces First Patient Randomized in Phase 2 INFINITY Trial of ADVM-022 Single Injection Gene Therapy for Diabetic Macular Edema (DME)

Read more ››
By: GlobenewsWire - 13 Jul 2020
Related companies:  Adverum Biotechnologies, Inc.

Phathom Pharmaceuticals Announces Appointment of Todd Branning as Chief Financial Officer

Read more ››
By: GlobenewsWire - 13 Jul 2020
Related companies:  Phathom Pharmaceuticals, Inc.

AnPac Bio Completed 1st Half Year with Increased ASP and Revenue

Read more ››
By: GlobenewsWire - 13 Jul 2020
Related companies:  Anpac Technology USA (Anpac Bio) | AnPac Bio-Medical Science Co., Ltd.

Arcutis Initiates Patient Enrollment in the Phase 2b Portion of the Phase 1/2b Study Evaluating ARQ-252 in Chronic Hand Eczema

Read more ››
By: GlobenewsWire - 13 Jul 2020
Related companies:  Arcutis Biotherapeutics, Inc.

Turning Point Therapeutics Names Andrew Partridge As Executive Vice President and Chief Commercial Officer

Read more ››
By: GlobenewsWire - 13 Jul 2020
Related companies:  Turning Point Therapeutics, Inc.

Benefits of Stereotaxis Robotic Technology in COVID-19 Patient Highlighted in Publication

Read more ››
By: GlobenewsWire - 13 Jul 2020
Related companies:  Stereotaxis, Inc.

DLT Resolution Reports First Quarter 2020 Financial Results

Read more ››
By: GlobenewsWire - 13 Jul 2020
«  1  2  3 4  5  6  7  8  9  10  11  12  13  14  15  16  17  18  19  20  21  22  23  24  25 »

Explore our database of over 50,000 companies